Fundraising FoxFidelity Investments — 2024 Investments
8 investments dated 2024 · listed companies and verified rows first · show all
MMI develops miniaturized robotic surgical instruments and platforms to enable surgeons to perform complex microsurgery and supermicrosurgery on delicate anatomical structures with greater precision.
HealthtechMedical DevicesRoboticsJacksonville, US
Mark Toland(Executive Officer, Director)inAndrew Cleeland(Director)Justin Lynch(Director)inTheresa Jean Cameron(Director)Caleb Moore(Executive Officer)Augusto Vianna Castello(Director)
Co-investorsAndera PartnersBioStar CapitalDeerfield Management CompanyRA CapitalCorewell Health VenturesFountain Healthcare Partners
Ankyra Therapeutics is a biopharmaceutical company developing drugs, with a team that has collectively contributed to bringing seven drugs to global market approval.
BiotechDeep TechHealthtechMedical DevicesAustin, US
Tillman Gerngross(Executive Officer, Director)
BoardTerrance McGuire(Director)
Co-investorsGV (Google Ventures)Mithril Capital ManagementPolaris PartnersSands Capital VenturesSpring Mountain Capital
Boosted.ai provides an AI platform for investment research that answers questions on stocks and themes and uses AI agents to generate reports and analysis for investment professionals.
AI & Machine LearningFintechSaaS
Joshua Pantony(Founder)inJon Dorando(Founder)in
Co-investorsDunamu & PartnersPortag3 VenturesPortage VenturesRBCxHarbourVest Partners (Canada)Spark Capital+1 more
Cardurion is a cardiovascular disease-focused company developing therapeutics, with a pipeline advanced through clinical development, trial design, regulatory affairs, and commercialization.
BiotechDigital HealthHealthtechMedical DevicesBurlington, US
Michael E. Mendelsohn(Founder and Chief Strategy Officer)inMichael Mendelsohn(Executive Officer, Director)
BoardEvan Rachlin(Director)Peter Lawrence(Executive Officer, Director)Edward Mathers(Director)Adam Koppel(Director)in
Co-investorsBain CapitalAscenta CapitalBain Capital Life SciencesDeepWork CapitalDelos CapitalDigitalis Ventures+7 more
City Therapeutics develops RNAi-based medicines targeting rare, specialty, and prevalent diseases using engineered trigger molecules and precision delivery ligands.
BiotechMedical DevicesCambridge, US
Mark Keating, MD(Co-founder)Kotaro Nakanishi, PhD(Co-founder)Yukihide Tomari, PhD(Co-founder)Phillip Zamore, PhD(Co-founder)Andy Orth(Chief Executive Officer)in
Co-investorsAN Venture PartnersARCH Venture PartnersSofinnova VenturesViking GlobalAltitude Ventures Management, LlcCasdin Capital+5 more
CoreWeave provides a cloud platform for running, observing, and improving production AI systems, including a product called Forge that supports the full model/agent iteration loop.
AI & Machine LearningCloud ComputingData & Infrastructure
Michael Intrator(Founder)inBrannin McBee(Founder)Brian Venturo(Founder)Peter Salanki(Founder)
Co-investorsAltra VentureCisco InvestmentsCoatue ManagementDragon CapitalFOG VenturesG Squared+21 more
Lightmatter is a product development firm that partners with companies to design and build digital products from concept through launch.
Developer ToolsHealthtechSaaSMountain View, US
Greg Hausheer(CEO and Founder)inBen Beecher(CTO and Founder)inNicholas Harris(Founder)inThomas Graham(Founder)inTrevor Moorman(COO)inMollie Fleury(Chief of Staff)in
Co-investorsGV (Google Ventures)Spark CapitalLockheed Martin VenturesT. Rowe PriceViking Global Investors
Triveni Bio develops genetics-informed antibody therapeutics aimed at treating complex immunology and inflammation (I&I) diseases.
BiotechDigital HealthHealthtech
Vishal Patelin
Co-investorsAscenta CapitalAtlas VentureBorealis VenturesBorealis VenturesMagnetic VenturesOrbiMed+4 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.